ReviewFrontiers in oncology2024

Exploring potential predictive biomarkers through historical perspectives on the evolution of systemic therapies into the emergence of neoadjuvant therapy for the treatment of hepatocellular carcinoma.

Chuanlei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.